Trilogy Metals Inc. (TMQ) AI Stock Analysis
TMQ AI stock analysis summary
AI ResearchTrilogy Metals Inc. (TMQ) is a base metals exploration company advancing the Upper Kobuk mineral projects in Northwest Alaska. Over the trailing twelve months ended August 31, 2026, the company generated $0 in revenue and posted diluted earnings per share of -$0.29. It holds $31.2M in cash and short-term investments against total debt of $81,000, while its shares have dropped 66.8% over the past year.
- Market cap
- $428.0M
- Revenue (TTM)
- $0
- P/E
- —
- 1Y return
- -66.8% S&P 500 16.8%
- Avg. target
- $6.57 178.5% vs last close
Bull case
- Trilogy Metals maintains a debt-free balance sheet with net cash of $31.1M and total debt of just $81,000 as of August 31, 2026.
- Wall Street analysts set a mean price target of $6.57, representing an implied upside of 178.5% from the last close of $2.36.
- Insiders hold 13.1% of the company's equity, aligning management incentives with shareholders across its 426,690 acres of exploration assets.
Bear case
- Trilogy Metals generated $0 in revenue over the trailing twelve months and consensus estimates project $0 in revenue through next fiscal year.
- The company's shares fell 66.8% over the past year, trailing the S&P 500 gain of 16.8%.
- Shareholders faced dilution as the company's share count increased 19.6% over a 5-year period.
What Trilogy Metals does
Trilogy Metals Inc., established in 2004 and formerly known as NovaCopper Inc., is an exploration company focused on the discovery and development of mineral properties primarily in the United States. Its core assets are the Upper Kobuk mineral projects, which cover approximately 426,690 acres in the Ambler mining district of Northwest Alaska. These properties prominently feature the Arctic deposit, known for polymetallic volcanogenic massive sulfide deposits, and the Bornite deposit, hosting carbonate-hosted copper-cobalt resources. Headquartered in Vancouver, Canada, the company operates with 5 employees and conducts exploration activities aimed at expanding its base metal mineral resources.
Growth and profitability
Trilogy Metals reported historical annual revenue growing from $4.5M in FY2015 to $19.2M in FY2019, representing a 4-year compound annual growth rate of 43.9%. However, profitability remained negative throughout that span, with net income moving from -$9.5M in FY2015 to -$27.9M in FY2019 and operating margin standing at -143.6% in FY2019. For the trailing twelve months ending August 31, 2026, revenue stood at $0, with both operating margin and profit margin at 0.0%. Diluted earnings per share reached -$0.29, alongside a return on equity of -39.0% and return on assets of -5.6%.
Balance sheet and cash flow
As of August 31, 2026, Trilogy Metals held $31.2M in cash and short-term investments alongside total debt of $81,000, resulting in net cash of $31.1M and a debt-to-equity ratio of 0.00. Total assets were $140.8M against shareholders' equity of $116.8M, supporting a current ratio of 1.33. Over the past five years, the company's share count increased by 19.6%.
Valuation and performance
Trilogy Metals carries a market cap of $428.0M and an enterprise value of $555.2M, trading at a price-to-book ratio of 5.1x. Because trailing revenue is $0, standard revenue and earnings multiples are unavailable, whereas the median of its US-listed Basic Materials peers reflects a trailing price-to-earnings ratio of 19.7x, an enterprise value to EBITDA of 10.5x, and a price-to-sales ratio of 1.8x. Over the past year, TMQ fell 66.8% compared to a 16.8% gain for the S&P 500, while its 5-year return of 9.8% lagged the S&P 500 return of 83.0%.
What analysts expect
Wall Street coverage consists of 3 Buy ratings, 3 Hold ratings, and 0 Sell or Strong Sell ratings. The consensus mean price target is $6.57, which represents a 178.5% premium over the last close of $2.36. For the fiscal year ending November 30, 2026, analysts estimate earnings per share of -$0.20 and revenue of $0, following 0 earnings per share beats over the last 4 quarters. Two analysts cover the following fiscal year, projecting earnings per share of -$0.09 and revenue of $0.
Key risks and what to watch
- Ongoing losses reflected in trailing earnings per share of -$0.29 continue to pressure equity capital.
- The stock displays heightened volatility with a beta of 1.69 and trades 40.0% below its 200-day average.
- Trilogy Metals failed to beat earnings per share estimates in any of the last 4 quarters.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this TMQ AI stock analysis
This page is an AI-written research summary of Trilogy Metals Inc. (TMQ). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: TMQ income statement, TMQ balance sheet, TMQ key metrics, TMQ analyst forecast, TMQ chart. See the TMQ stock overview for the latest quote and news.
TMQ AI stock analysis FAQ
Does Trilogy Metals pay a dividend?
No, Trilogy Metals does not pay a dividend, and no dividend yield or distribution history is reported.
What are Trilogy Metals' primary exploration assets?
The company's flagship assets are the Upper Kobuk mineral projects covering approximately 426,690 acres in the Ambler mining district of Northwest Alaska, which include the Arctic polymetallic deposit and the Bornite copper-cobalt deposit.
What is Trilogy Metals' financial position?
As of August 31, 2026, Trilogy Metals held $31.2M in cash and short-term investments against total debt of $81,000, maintaining a current ratio of 1.33 and net cash of $31.1M.
What is the Wall Street analyst consensus for TMQ stock?
Analysts maintain 3 Buy ratings and 3 Hold ratings, with a mean price target of $6.57, which is 178.5% above its closing price of $2.36 on October 16, 2026.